Australia's largest stock trading and investment forum Australia's #1 stock forum

Background story to CV19 / HCQ and IVM treatments, page-6572

First 6572 Last

Share
Profile

Follow
stevenjd

26,766 Posts.

3113

27/05/22

10:08

Post #: 61654922
Share

Originally posted by walbrook: ↑

I-RECOVER: Post-Vaccine Treatment

Management of Post-Vaccine Syndrome
Major public health authorities do not recognize post-COVID-vaccine injuries; and there is no specific ICD classification code for this disease. However, while no official definition exists, a temporal correlation between a patient receiving a COVID-19 vaccine and beginning or worsening of clinical manifestations is sufficient to diagnose as a COVID-19 vaccine-induced injury when the symptoms are unexplained by other concurrent causes.
Since there are no published reports detailing the management of vaccine-injured patients, our treatment approach is based on the postulated pathogenetic mechanism, clinical observation, and patient anecdotes. Treatment must be individualized according to each patient’s presenting symptoms and disease syndromes. It is likely that not all patients will respond equally to the same intervention; a particular intervention may be life saving for one patient and totally ineffective for another.
Early treatment is essential; it is likely that the response to treatment will be attenuated when treatment is delayed.
For detailed instructions and sources, downloadPDF.
I-RECOVER: Post-Vaccine Treatment

Version 1, May 25, 2022

I-RECOVER: Post-Vaccine Treatment - FLCCC | Front Line COVID-19 Critical Care Alliance (covid19criticalcare.com)

Expand
5 Upvote

Reply

There are more pages in this discussion • 2,240 more messages in this thread...

First 6572 Last

Background story to CV19 / HCQ and IVM treatments, page-6572

I-RECOVER: Post-Vaccine Treatment

Featured News

Recharged Prospects: 'Watts' on the horizon for copper & lithium

BHP confirms £31.1B takeover bid for Anglo American

Regal copper grades at Gascoyne play see shares jump 33% for Augustus

Carnarvon revs up for revised Dorado Development

Are there gains to be made with the grocery giants?

Featured News

Background story to CV19 / HCQ and IVM treatments, page-6572

Featured News

Top Stories

Recharged Prospects: 'Watts' on the horizon for copper & lithium

BHP confirms £31.1B takeover bid for Anglo American

Regal copper grades at Gascoyne play see shares jump 33% for Augustus

Carnarvon revs up for revised Dorado Development

Are there gains to be made with the grocery giants?

Featured News